Arbutus Biopharma Corp: Form 8-K, filed Jul 16, 2015
Filed with the SEC on Jul 16, 2015 and accepted by EDGAR at Jul 16, 2015, 17:26 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 5.02 Departure or appointment of officers or directors
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000912282-15-000243. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.